ABCG2 and cancer: Since the inhibition of glycolysis inactivates ABC transporters to retain anti-cancer agents in malignant cells (Figure 2B–C), we next examined the tumoricidal effects of anti-cancer agents in combination with 3BrPA in ABC transporter-expressing malignant cells.